Susquehanna International Group, LLP Gossamer Bio, Inc. Transaction History
Susquehanna International Group, LLP
- $688 Billion
- Q2 2025
A detailed history of Susquehanna International Group, LLP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 382,677 shares of GOSS stock, worth $738,566. This represents 0.0% of its overall portfolio holdings.
Number of Shares
382,677
Previous 2,916,109
86.88%
Holding current value
$738,566
Previous $3.21 Million
85.34%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding GOSS
# of Institutions
137Shares Held
159MCall Options Held
2.79MPut Options Held
130K-
Octagon Capital Advisors LP New York, NY18.4MShares$35.4 Million8.57% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$34.9 Million1.84% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.4MShares$22 Million0.0% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$15.5 Million5.25% of portfolio
-
Acadian Asset Management LLC Boston, MA7.15MShares$13.8 Million0.02% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $181M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...